Books Pharmaceutical Companies Vaccines 
pharmaphorum
JULY 1, 2025
Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)
pharmaphorum
SEPTEMBER 6, 2022
The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s acceptance of advice from the Joint Committee on Vaccination and Immunisation (JCVI) to go ahead with rollout of Pfizer’s bivalent 30mg booster shot this week. million)” during the first year of vaccinations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 23, 2025
The Orange Book is the reference, and it allows the FDA to declare something [to be] therapeutically equivalent. In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. If it’s a sole-source drug, it gets its own unique J-code.
pharmaphorum
JUNE 1, 2022
Due to the pandemic, more people than ever had to turn to digital healthcare to achieve basic activities, such as speaking with a doctor or booking a visit with a healthcare professional. In the case of the pandemic, this resulted in vaccine hesitancy in some people, even when they were potentially at risk. The training challenge.
European Pharmaceutical Review
JANUARY 16, 2023
” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. The previous record for vaccine development and approval was four years for the measles vaccine.
European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. While the data was based on responses from 292 manufacturers across all sectors, the outcomes are applicable to pharmaceutical manufacturing. Meath opened last month. The new £26.4 The new £26.4
PharmaShots
MARCH 9, 2023
With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceutical company under her direction. Additionally, the business has been ranked first in the pharmaceutical industry for nine years running on Fortune magazine's list of the "World's Most Admired Companies.
Expert insights. Personalized for you.
66 
Let's personalize your content